Oppilan Pharma Announces Positive Phase 1 Data for its Ulcerative Colitis Drug OPL-002 at Digestive Disease Week 2020 Virtual Scientific Program

NASDAQ Market News June 23, 2020

NASDAQ Market News
Click here to email author

Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19

Next-generation Sequencing (NGS) Services Market Worth $13.1 Billion by 2025, Growing at a CAGR of 20.5% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®

Ads